Search

Sonya N. Wright

Examiner (ID: 11509, Phone: (571)272-5857 , Office: P/1672 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1621, 1626, 1672, 1613, 1762, 1796, 1614
Total Applications
765
Issued Applications
560
Pending Applications
32
Abandoned Applications
177

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6952902 [patent_doc_number] => 20050227997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Selective inhibition of aggrecanase in osteoarthritis treatment' [patent_app_type] => utility [patent_app_number] => 11/120376 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27381 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227997.pdf [firstpage_image] =>[orig_patent_app_number] => 11120376 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/120376
Selective inhibition of aggrecanase in osteoarthritis treatment May 2, 2005 Issued
Array ( [id] => 6957879 [patent_doc_number] => 20050214249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates' [patent_app_type] => utility [patent_app_number] => 11/104232 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20775 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214249.pdf [firstpage_image] =>[orig_patent_app_number] => 11104232 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/104232
O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates Apr 11, 2005 Issued
Array ( [id] => 645733 [patent_doc_number] => 07119199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Process for the preparation of pyridopyrimidones' [patent_app_type] => utility [patent_app_number] => 11/029139 [patent_app_country] => US [patent_app_date] => 2004-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1977 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119199.pdf [firstpage_image] =>[orig_patent_app_number] => 11029139 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/029139
Process for the preparation of pyridopyrimidones Dec 30, 2004 Issued
Array ( [id] => 6991463 [patent_doc_number] => 20050090500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Stable polymorph of N-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof' [patent_app_type] => utility [patent_app_number] => 10/992266 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13468 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090500.pdf [firstpage_image] =>[orig_patent_app_number] => 10992266 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/992266
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride Nov 17, 2004 Issued
Array ( [id] => 655279 [patent_doc_number] => 07109332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => '2,4-dioxo-3-quinazolinylaryl sulfonylureas' [patent_app_type] => utility [patent_app_number] => 10/956004 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13533 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109332.pdf [firstpage_image] =>[orig_patent_app_number] => 10956004 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/956004
2,4-dioxo-3-quinazolinylaryl sulfonylureas Sep 28, 2004 Issued
Array ( [id] => 7127925 [patent_doc_number] => 20050059669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity' [patent_app_type] => utility [patent_app_number] => 10/944712 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53151 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059669.pdf [firstpage_image] =>[orig_patent_app_number] => 10944712 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/944712
M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity Sep 20, 2004 Abandoned
Array ( [id] => 531823 [patent_doc_number] => 07179805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => '7-amino alkylidenyl-heterocyclic quinolones and naphthyridones' [patent_app_type] => utility [patent_app_number] => 10/937238 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18131 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179805.pdf [firstpage_image] =>[orig_patent_app_number] => 10937238 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/937238
7-amino alkylidenyl-heterocyclic quinolones and naphthyridones Sep 8, 2004 Issued
Array ( [id] => 7163201 [patent_doc_number] => 20050085447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Pyrido[3,4-d]pyrimidine derivatives as matrix metalloproteinase-13 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/921055 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 48180 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085447.pdf [firstpage_image] =>[orig_patent_app_number] => 10921055 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/921055
Pyrido[3,4-d]pyrimidine derivatives as matrix metalloproteinase-13 inhibitors Aug 17, 2004 Abandoned
Array ( [id] => 695888 [patent_doc_number] => 07071333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same' [patent_app_type] => utility [patent_app_number] => 10/901677 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14318 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071333.pdf [firstpage_image] =>[orig_patent_app_number] => 10901677 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/901677
Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same Jul 28, 2004 Issued
Array ( [id] => 7378491 [patent_doc_number] => 20040220193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound' [patent_app_type] => new [patent_app_number] => 10/855357 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 79452 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220193.pdf [firstpage_image] =>[orig_patent_app_number] => 10855357 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855357
Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound May 27, 2004 Abandoned
Array ( [id] => 7255449 [patent_doc_number] => 20050075353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Quinazolines and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 10/852076 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20028 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075353.pdf [firstpage_image] =>[orig_patent_app_number] => 10852076 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852076
Haloanilino quinazolines and therapeutic use thereof May 23, 2004 Issued
Array ( [id] => 750926 [patent_doc_number] => 07022850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Bicyclicpyrimidones and their use to treat diseases' [patent_app_type] => utility [patent_app_number] => 10/848089 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19243 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022850.pdf [firstpage_image] =>[orig_patent_app_number] => 10848089 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848089
Bicyclicpyrimidones and their use to treat diseases May 17, 2004 Issued
Array ( [id] => 699739 [patent_doc_number] => 07067659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/829940 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3202 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067659.pdf [firstpage_image] =>[orig_patent_app_number] => 10829940 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/829940
Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof Apr 22, 2004 Issued
Array ( [id] => 7378380 [patent_doc_number] => 20040220186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/828485 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18570 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220186.pdf [firstpage_image] =>[orig_patent_app_number] => 10828485 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828485
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease Apr 19, 2004 Abandoned
Array ( [id] => 7239232 [patent_doc_number] => 20040157863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Triazolopyrimidines' [patent_app_type] => new [patent_app_number] => 10/474948 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23356 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157863.pdf [firstpage_image] =>[orig_patent_app_number] => 10474948 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/474948
Triazolopyrimidines Apr 6, 2004 Abandoned
Array ( [id] => 7190754 [patent_doc_number] => 20040204427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Pyrimido compounds having antiproliferative activity' [patent_app_type] => new [patent_app_number] => 10/817697 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32655 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204427.pdf [firstpage_image] =>[orig_patent_app_number] => 10817697 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/817697
Pyrimido compounds having antiproliferative activity Apr 1, 2004 Issued
Array ( [id] => 7351903 [patent_doc_number] => 20040248904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'New piperidinylamino-thieno[2,3-d] pyrimidine compounds' [patent_app_type] => new [patent_app_number] => 10/815417 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25423 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248904.pdf [firstpage_image] =>[orig_patent_app_number] => 10815417 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/815417
Piperidinylamino-thieno[2,3-d] pyrimidine compounds Mar 30, 2004 Issued
Array ( [id] => 7468798 [patent_doc_number] => 20040167158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Heterocyclic compounds for the treatment of migraine' [patent_app_type] => new [patent_app_number] => 10/784673 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17132 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167158.pdf [firstpage_image] =>[orig_patent_app_number] => 10784673 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/784673
Heterocyclic compounds for the treatment of migraine Feb 23, 2004 Abandoned
Array ( [id] => 645751 [patent_doc_number] => 07119200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Pyrazolopyrimidines as cyclin dependent kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/776988 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66402 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119200.pdf [firstpage_image] =>[orig_patent_app_number] => 10776988 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/776988
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Feb 10, 2004 Issued
Array ( [id] => 7239618 [patent_doc_number] => 20040157896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Methods for treating neurodegenerative disorders using aspartyl protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/774262 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18615 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157896.pdf [firstpage_image] =>[orig_patent_app_number] => 10774262 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/774262
Methods for treating neurodegenerative disorders using aspartyl protease inhibitors Feb 4, 2004 Issued
Menu